Company Filing History:
2 out of 2,202 
2 out of 5,468 
Years Active: 1997-1999
Title: The Innovative Contributions of Rita B. Moyes
Introduction: Rita B. Moyes, a distinguished inventor based in College Station, TX, has made significant contributions to the field of immunology through her innovative research and patent developments. With a total of two patents to her name, she has emerged as a prominent figure in the scientific community.
Latest Patents: Rita B. Moyes' latest patents focus on a method to produce granulocyte colony-stimulating factor from immortal avian T lymphocyte cell lines. These cell lines are developed from T cells extracted from fowl that have been hyperimmunized in vivo. Her process begins with the activation of T cells, which are then exposed in vitro to a mitogen effective for secondary stimulation. Subsequently, the T cells are virally transformed to create an immortal cell line. When cultured in vitro, these cell lines generate and secrete immune lymphokines that can be administered to fowl, enhancing their resistance to infections.
Career Highlights: Throughout her career, Rita B. Moyes has worked with some of the leading institutions in the research sector. Notably, she has collaborated with the United States of America as represented by the Secretary of Agriculture and the Texas A&M University System. Her work has been instrumental in advancing the understanding of immune responses in avian species.
Collaborations: Rita's collaborations with esteemed colleagues, including Michael H. Kogut and John R. DeLoach, have further enriched her research, allowing for a multidisciplinary approach to her innovations. Together, they have contributed significantly to the evolution of vaccine development and immunotherapy in animals.
Conclusion: Rita B. Moyes exemplifies the spirit of innovation in the field of immunology. Her work on developing immortal avian T lymphocyte cell lines not only showcases her inventive mind but also emphasizes the importance of collaboration in scientific research. With her ongoing contributions, she continues to pave the way for advancements in veterinary immunology and offers hope for improved disease resistance in fowl.